G1 Therapeutics to Present Additional Trilaciclib Phase 2 Small Cell Lung Cancer Data at 2019 American Society of Clinical Oncology (ASCO) Annual Meeting

NEXT STORY
Kiniksa to Present Data on the Burden of Disease in Patients with Recurrent Pericarditis at the International Society for Pharmacoeconomics and Outcomes Research
PREV STORY
Geron Continues to Build Senior Leadership of Its Development Team
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Press release: Terveystalo renews its management structure – decision making and service development closer to the customer

The business environment in health care is experiencing great change. In order to ensure ...

author_avatar
NASDAQ Market News

Zynerba Pharmaceuticals Presents Health State Utility Index Data on Severity of Fragile X Syndrome (FXS) and Diagnostic Challenges Faced by Caregivers 

author_avatar
NASDAQ Market News

Ocuphire Expands Prestigious Medical Advisory Board with Six New KOLs to Support Advancement of Late-Stage Ophthalmic Assets Nyxol® and APX3330

author_avatar
NASDAQ Market News